University of Pittsburgh

Robert M. DiFazio, PhD

Postdoctoral Fellow





	
	


			

		Dr. Robert DiFazio	
		

		

	
Contact

    	
		
	
	
	    

    
    
   
    
   
    
        
    
   
   
   
   
   
   
    
    
	
	
	
		
		
	



	
Education
	
	

	
PhD in Molecular Virology and Microbiology, University of Pittsburgh, School of Medicine, 2017
BS in Letters and Sciences with High Distinction in Chemistry, University of Illinois at Urbana-Champaign, 2010
        

              
   
  
 
 


  
 
 
 
 
 
 
 
 	
Mentor
	
	

	
JoAnne Flynn, PhD
        

                
        
        
        
        	
Dissertation
	
	

	Determination of correlates of protection against tuberculosis in nonhuman primate models	
	


        
        
        
        
 
 
   
   
















        













	
Areas of Interest
	
	

	Tuberculosis, immunology, vaccine development	
	






	
Why I Chose Pitt
	
	

	
I chose this program due to the variety of research projects within my area of interest: vaccine development. The University of Pittsburgh also has excellent resources for this type of research, including the Center for Vaccine Research and the Regional Biocontainment Laboratory. In addition, Pittsburgh is a great city in which you can work and play!
Abstracts
DiFazio RM, Williams JJ, Hergenrother PJ. Exploitation of toxin-antitoxin systems in combating multi-drug resistance. Proctor and Gamble Company Student Research Awards. Champaign, IL. Apr 2011.
DiFazio RM, Williams JJ, Hergenrother PJ. Exploitation of toxin-antitoxin systems in combating multi-drug resistance. Frank and Sara McKnight Prize in Biochemistry. University of Texas SWMC, Dallas, TX. Nov. 2010.
Following his graduation from the University of Pittsburgh, Dr. DiFazio accepted a position at Emory Univeristy in the laboratory of Dr. Bali Pulendran, PhD, in the Emory Vaccine Center.
	
	




	
Publications
	
	

	
Williams, J. J; Halvorsen, E. M; Dwyer, E. M; DiFazio, R. M; and Hergenrother, P. J. (2011) Toxin-antitoxin (TA) systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett. 322: 41-50. |  View Abstract